Halozyme Therapeutics Inc (NAS:HALO)
$ 102.62 +0.020 (+0.02%) Market Cap: 11.65 Bil Enterprise Value: 13.56 Bil PE Ratio: 30.63 PB Ratio: 86.67 GF Score: 81/100

Halozyme Therapeutics Inc (HALO) Transcripts

  • 1